Sangamo Therapeutics (SGMOQ) Share-based Compensation (2009 - 2026)
Sangamo Therapeutics' Share-based Compensation came in at $992,000 for Q1 2026, down 61.8% from $2.6 million a year earlier and down 53.4% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Share-based Compensation (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Sangamo Therapeutics reported Share-based Compensation of $7.48 million, down 39.0% year-over-year; for FY2025, it came in at $9.08 million, down 26.7% from FY2024.
- Share-based Compensation has declined in each of the last four years, with a five-year compound annual growth rate of -18.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $12.38 million in FY2024 (-54.7%), $27.36 million in FY2023 (-13.5%), $31.65 million in FY2022 (-4.0%) and $32.96 million in FY2021 (+28.2%).
- The Q1 2026 figure represents the lowest quarterly Share-based Compensation in data going back to Q3 2010.
- Year-over-year, Share-based Compensation has declined for 12 consecutive quarters, with an average decline of 39.0% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q2 2021 (growth of 40.2%), and the weakest in Q1 2024 (a decline of 67.1%).
- Business Quant data shows SGMOQ's Share-based Compensation at $2.13 million (Q4 2025), $2.13 million (Q3 2025) and $2.23 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - | 992,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 992,000.00 |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 6.11 Mn |
| Sep 30, 2023 | 6.19 Mn |
| Jun 30, 2023 | 6.79 Mn |
| Mar 31, 2023 | 8.28 Mn |
| Dec 31, 2022 | 8.25 Mn |
| Sep 30, 2022 | 7.79 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Mar 31, 2022 | 7.69 Mn |
| Dec 31, 2021 | 8.08 Mn |
| Sep 30, 2021 | 7.87 Mn |
| Jun 30, 2021 | 9.48 Mn |
API Access
Sangamo Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();